GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Physitrack PLC (OSTO:PTRK) » Definitions » 3-Year Sharpe Ratio

Physitrack (OSTO:PTRK) 3-Year Sharpe Ratio : -1.15 (As of Jan. 31, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Physitrack 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-01-31), Physitrack's 3-Year Sharpe Ratio is -1.15.


Competitive Comparison of Physitrack's 3-Year Sharpe Ratio

For the Health Information Services subindustry, Physitrack's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Physitrack's 3-Year Sharpe Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Physitrack's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Physitrack's 3-Year Sharpe Ratio falls into.



Physitrack 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


Physitrack  (OSTO:PTRK) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Physitrack 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Physitrack's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Physitrack Business Description

Traded in Other Exchanges
N/A
Address
140 London Wall, Bastion House 6th Floor, London, GBR, EC2Y 5DN
Physitrack PLC is a digital healthcare provider, focused on B2B physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World.

Physitrack Headlines

No Headlines